TH-302: SPA received

Threshold received an SPA from FDA for a planned open-label Phase III

Read the full 127 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE